Sunday, February 27, 2011
FDA grants meeting on Avastin for breast cancer
WASHINGTON (AP) -- The Food and Drug Administration has granted Swiss drugmaker Roche a first-of-a-kind public hearing to defend the effectiveness of its drug Avastin for treating breast cancer, just months after the agency ruled that the drug is ineffective for that use.Roche said Thursday it will make its case at the two-day hearing in June for keeping the
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment